Arcturus Therapeutics Holdings Inc. (ARCT)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 708.68M |
| Enterprise value | 446.89M |
| Trailing P/E | N/A |
| Forward P/E | 2.48 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 4.44 |
| Price/book (mrq) | 2.54 |
| Enterprise value/revenue | 2.83 |
| Enterprise value/EBITDA | -18.49 |
Trading information
Stock price history
| Beta (5Y monthly) | 2.60 |
| 52-week change 3 | -4.91% |
| S&P500 52-week change 3 | 21.23% |
| 52-week high 3 | 43.81 |
| 52-week low 3 | 17.52 |
| 50-day moving average 3 | 35.28 |
| 200-day moving average 3 | 30.01 |
Share statistics
| Avg vol (3-month) 3 | 481.15k |
| Avg vol (10-day) 3 | 538.96k |
| Shares outstanding 5 | 26.92M |
| Implied shares outstanding 6 | 26.92M |
| Float 8 | 24.55M |
| % held by insiders 1 | 8.75% |
| % held by institutions 1 | 90.49% |
| Shares short (28 Mar 2024) 4 | 4.81M |
| Short ratio (28 Mar 2024) 4 | 8.56 |
| Short % of float (28 Mar 2024) 4 | 23.80% |
| Short % of shares outstanding (28 Mar 2024) 4 | 17.87% |
| Shares short (prior month 29 Feb 2024) 4 | 4.22M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 16 Nov 2017 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:7 |
| Last split date 3 | 16 Nov 2017 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -17.82% |
| Operating margin (ttm) | -59.22% |
Management effectiveness
| Return on assets (ttm) | -11.11% |
| Return on equity (ttm) | -10.83% |
Income statement
| Revenue (ttm) | 166.8M |
| Revenue per share (ttm) | 6.26 |
| Quarterly revenue growth (yoy) | -80.80% |
| Gross profit (ttm) | N/A |
| EBITDA | -75.25M |
| Net income avi to common (ttm) | -29.73M |
| Diluted EPS (ttm) | -1.12 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 292M |
| Total cash per share (mrq) | 10.85 |
| Total debt (mrq) | 30.22M |
| Total debt/equity (mrq) | 10.85% |
| Current ratio (mrq) | 4.72 |
| Book value per share (mrq) | 10.38 |
Cash flow statement
| Operating cash flow (ttm) | -18.1M |
| Levered free cash flow (ttm) | -82.55M |
© 2024 Yahoo. All rights reserved.